Session information

Oral Presentation

[31-412-am] Diseases and therapies of central nervous system

Sun. Mar 31, 2024 9:45 AM - 10:45 AM [Room 412] Conference Center 412 (4F)

Chair: Norikazu Kiguchi, Takahide Shuto

+Add all to schedule

9:45 AM - 9:57 AM

[31-412-am06S] Noggin ameliorated traumatic brain injury-evoked BBB disorders in mice by inhibition of BMP4

○miho yasunaga¹, Fuyuko Takata¹, Nanako Tajima¹, Sanami Kuga¹, Junko Mizoguti¹, Miki Yokoya¹, Naotaka Aridome¹, Takurou Iwao¹, Shinya Dohgu¹ (1. Dept. Pharmaceut. Care & Health Sci., Fac. Pharmaceut. Sci., Fukuoka Univ. )

9:57 AM - 10:09 AM

[31-412-am07S] Identification of the genetic loci responsible for copper accumulation in the brain of Down syndrome model mouse using mouse models carrying deletions on the trisomic region

○Yurina Tatsumi¹, Michiko Saito¹, Shuji Takada², Eri Kawashita¹, Kazuhiro Yamakawa³, Satoshi Akiba¹, Keiichi Ishihara¹ (1. Kyoto Pharm. Univ., 2. Natl. Centr. Child Health Dev., 3. Nagoya City Univ. Grad. Sch. Med. Sci.)

10:09 AM - 10:21 AM

[31-412-am08S] Effects of TGF-β inhibitors on a murine model of retinal vein occlusion

○Kotaro Inaoka¹, Yae Hidaka¹, Shinsuke Nakamura¹, Yoshiki Kuse¹, Masamitsu Shimazawa¹ (1. Mole. Pharm., Dept. of Biofunc. Evalu., Gifu Pharm. Univ)

10:21 AM - 10:33 AM

[31-412-am09S] Involvement of decapping scavenger enzyme DcpS in progression of glioblastoma

○Urara Kudo¹, Shinsuke Nakamura¹, Yoshiki Kuse¹, Masamitsu Shimazawa¹ (1. Mole. Pharm., Dept. of Biofunc. Evalu., Gifu Pharm. Univ.)

10:33 AM - 10:45 AM

[31-412-am10S] Possible changes in the tumor progression under the conditional knockout of Oprm1 gene in periphery

○Minori Tabata¹, Yusuke Hamada^1,2, Mutsumi Kamemoto¹, Satomi Ushiki¹, Yukari Suda^1,2, Naoko Kuzumaki^1,2, Minoru Narita^1,2 (1. Hoshi Univ., 2. Natl. Cancer Ctr. Res. Inst.)